Lee Danner & Bass Inc. Has $3.82 Million Stock Holdings in Henry Schein, Inc. $HSIC

Key Points

• Lee Danner & Bass Inc. increased its holdings in Henry Schein, Inc. by 44.6% during Q2, now owning 52,335 shares valued at approximately $3.82 million.
• Analysts have mixed ratings for Henry Schein, with a consensus rating of "Hold" and a target price averaging $76.67, reflecting recent downgrades from several firms.
• Henry Schein reported Q2 earnings of $1.10 per share, which was below analyst expectations, despite a year-over-year revenue increase of 3.3% to $3.24 billion.

Lee Danner & Bass Inc. grew its position in Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 44.6% in the second quarter, according to its most recent filing with the SEC. The fund owned 52,335 shares of the company's stock after acquiring an additional 16,150 shares during the period. Lee Danner & Bass Inc.'s holdings in Henry Schein were worth $3,823,000 as of its most recent filing with the SEC.

Several other large investors have also bought and sold shares of the stock. Sumitomo Mitsui Trust Group Inc. raised its position in shares of Henry Schein by 24.8% in the 2nd quarter. Sumitomo Mitsui Trust Group Inc. now owns 6,272 shares of the company's stock worth $458,000 after acquiring an additional 1,247 shares in the last quarter. Asset Management One Co. Ltd. raised its holdings in shares of Henry Schein by 9.8% in the 2nd quarter. Asset Management One Co. Ltd. now owns 8,286 shares of the company's stock worth $605,000 after purchasing an additional 739 shares during the period. First Citizens Bank & Trust Co. raised its holdings in Henry Schein by 36.5% during the 2nd quarter. First Citizens Bank & Trust Co. now owns 96,475 shares of the company's stock valued at $7,047,000 after acquiring an additional 25,781 shares during the period. Forum Financial Management LP grew its position in shares of Henry Schein by 30.3% during the 2nd quarter. Forum Financial Management LP now owns 4,180 shares of the company's stock valued at $305,000 after purchasing an additional 971 shares in the last quarter. Finally, Foster & Motley Inc. purchased a new position in Henry Schein in the second quarter worth $244,000. 96.62% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

HSIC has been the subject of several recent analyst reports. Baird R W downgraded shares of Henry Schein from a "strong-buy" rating to a "hold" rating in a research note on Monday, July 14th. UBS Group cut their price objective on shares of Henry Schein from $75.00 to $70.00 and set a "neutral" rating on the stock in a report on Wednesday, August 6th. Leerink Partners set a $75.00 price target on shares of Henry Schein in a report on Monday, July 14th. Robert W. Baird restated a "neutral" rating and issued a $72.00 target price (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Henry Schein from $80.00 to $76.00 and set an "overweight" rating on the stock in a report on Thursday, August 7th. Five research analysts have rated the stock with a Buy rating and eight have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus target price of $76.67.

Henry Schein Price Performance

HSIC stock opened at $63.73 on Friday. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a 50-day moving average price of $66.81 and a 200 day moving average price of $68.52. The stock has a market cap of $7.73 billion, a PE ratio of 20.56, a P/E/G ratio of 2.10 and a beta of 0.81.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share for the quarter, missing analysts' consensus estimates of $1.19 by ($0.09). Henry Schein had a net margin of 3.05% and a return on equity of 14.36%. The company had revenue of $3.24 billion for the quarter, compared to the consensus estimate of $3.22 billion. During the same quarter in the previous year, the business earned $1.23 EPS. The company's quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.